1. Rodenhuis,S. ( 1996 ) Ras oncogenes and human lung cancer. In Pass,H., Mitchell,J.B., Johnson,D.H. and Turrisi,A.T. (eds) Lung Cancer Principles and Practice . Lippincott-Raven, New York, pp. 73–82.
2. Greenblatt,M.S., Bennett,W.P., Hollstein,M. and Harris,C.C. ( 1994 ) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res. , 54 , 4855 –4878.
3. Merlo,A., Gabrielson,E., Askin,F. and Sidransky,D. ( 1994 ) Frequent loss of chromosome 9 in human primary non-small cell lung cancer. Cancer Res. , 54 , 640 –642.
4. Kamb,A., Gruis,N.A., Weaver-Feldhaus,J., Liu,Q., Harshman,K., Tavtigian,S.V., Stockert,E., Day,R.S.III, Johnson,B.E. and Skolnick,M.H. ( 1994 ) A cell cycle regulator potentially involved in genesis of many tumor types. Science , 264 , 436 –440.
5. Merlo,A., Herman,J.G., Mao,L., Lee,D.J., Gabrielson,E., Burger,P.C., Baylin,S.B. and Sidransky,D. ( 1995 ) 5′CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat. Med. , 1 , 633 –634.